跳至主要内容
临床试验/CTRI/2025/07/089981
CTRI/2025/07/089981尚未招募1 期

A Randomized Controlled Trial to Compare the Effectiveness of Jeemutak Varti and Corect Suppository in The Reduction of Size of Grade I And Grade II Haemorrhoids w.s.r. to Abhyantar Arsha

shri ayurved mahavidayala pakwasa and samanvaya rugnalaya nagpur1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2025年7月25日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
64
试验地点
1
主要终点
it is expected to end of the study we should able to Know the effcacy of ayurvedic treatment protocol in the managment of second degree hemorroids

研究概览

简要总结

This study aims to compare the clinical efficacy of Jeemutak Varti, a classical Ayurvedic formulation, and Corect Suppository, a modern pharmaceutical formulation, in managing Grade I and Grade II internal hemorrhoids (Abhyantar Arsha).A randomized controlled trial was conducted on 64 patients, equally divided into two groups. Group A received Jeemutak Varti and Group B received Corect Suppository per rectum for 14 days. Parameters such as pile mass size, pain, bleeding per rectum, and discomfort were assessed before, during, and after treatment. The study seeks to provide a comparative understanding of traditional and modern therapeutic approaches in Arsha Chikitsa

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed patients of I and II grade Haemorrhoids in the age group of 20-60 yrs.
  • Selection will be irrespective of gender, religion, education and socio-economic status of the patients.

排除标准

  • Patients with grade III and IV degree Haemorrhoids.
  • Patients suffering from different pathologies of anal canal and rectum like carcinoma rectum and anal canal, ulcerative colitis, proctitis etc.
  • Patients with uncontrolled diabetes mellitus, immune-compromised, liver cirrhosis patients.
  • Known patients of portal hypertension will be excluded.

结局指标

主要结局

it is expected to end of the study we should able to Know the effcacy of ayurvedic treatment protocol in the managment of second degree hemorroids

时间窗: it is expected to end of the study we should able to Know the effcacy of allopathic suppository treatment protocol in the managment of second degree hemorroids

次要结局

  • it is expected to end of the study we should able to Know the effcacy of allopathic suppository treatment protocol in the managment of second degree hemorroids(it is expected to it take 1 year & 8 months)

研究者

发起方
shri ayurved mahavidayala pakwasa and samanvaya rugnalaya nagpur
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

DR LOCHAN SINGH KHANDAGALE

SHRI AYURVED MAHAVIDAYALAYA AND PAKWSA SAMNVAYA RUGNALAYA

研究点 (1)

Loading locations...

相似试验